Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025
Surgical trapping and everolimus therapy for a giant internal carotid aneurysm in pediatric tuberous sclerosis complex: case report and literature review.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kajiwara Sosho, Otsu Yusuke, Kikuchi Jin, Sakata Kiyohiko, Hamamoto Yuuta, Hirohata Masaru, Nakamura Hideo, Morioka Motohiro
Аннотация
BACKGROUND: Tuberous sclerosis complex (TSC) is an autosomal dominant, multiorgan neurocutaneous syndrome. Intracranial aneurysms associated with TSC are extremely rare, and most reports are limited to single cases. The optimal management strategies remain undefined, and the efficacy of everolimus, an mTOR inhibitor, for vascular lesions in TSC patients has not been established.
CASE PRESENTATION: We describe a 4-year-old boy with TSC who developed a giant internal carotid artery (ICA) aneurysm complicated by cavernous sinus syndrome. The patient presented with diplopia and right ptosis. Imaging revealed marked ICA dilatation and a partially thrombosed aneurysm. Balloon occlusion testing confirmed adequate collateral flow via the posterior communicating artery, permitting ICA trapping without bypass. Surgical trapping was performed successfully, and everolimus was initiated postoperatively. Symptoms resolved immediately, and no new aneurysms were detected over 3 years of follow-up.
CONCLUSION: This is the first reported pediatric case of a giant ICA aneurysm with cavernous sinus syndrome in a TSC patient managed with surgical trapping and postoperative everolimus. Careful surgical planning combined with pharmacotherapy may offer a potential treatment option in selected TSC patients. Further studies are warranted to evaluate the long-term efficacy of everolimus in preventing aneurysm formation.
CASE PRESENTATION: We describe a 4-year-old boy with TSC who developed a giant internal carotid artery (ICA) aneurysm complicated by cavernous sinus syndrome. The patient presented with diplopia and right ptosis. Imaging revealed marked ICA dilatation and a partially thrombosed aneurysm. Balloon occlusion testing confirmed adequate collateral flow via the posterior communicating artery, permitting ICA trapping without bypass. Surgical trapping was performed successfully, and everolimus was initiated postoperatively. Symptoms resolved immediately, and no new aneurysms were detected over 3 years of follow-up.
CONCLUSION: This is the first reported pediatric case of a giant ICA aneurysm with cavernous sinus syndrome in a TSC patient managed with surgical trapping and postoperative everolimus. Careful surgical planning combined with pharmacotherapy may offer a potential treatment option in selected TSC patients. Further studies are warranted to evaluate the long-term efficacy of everolimus in preventing aneurysm formation.